Rheumatoid Arthritis Therapeutics Market to Hit USD 33,958.4 Million with 4.6% CAGR; Improved Reimbursement Policies to Aid Expansion, says Fortune Business Insights™
09 nov. 2020 06h37 HE
|
Fortune Business Insights
Pune, Nov. 09, 2020 (GLOBE NEWSWIRE) -- According to the report, the global rheumatoid arthritis therapeutics market size is anticipated to exhibit 4.6% CAGR and reach valuation of US$ 33,958.4 Mn...
Exagen Inc. Announces Study to Evaluate Emergence of Autoimmune Diseases After COVID-19 Infection
02 nov. 2020 08h25 HE
|
Exagen Inc.
SAN DIEGO, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today...
Exagen to Announce Third Quarter Financial Results on November 10, 2020
27 oct. 2020 16h05 HE
|
Exagen Inc.
SAN DIEGO, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
Exagen Showcases Six Scientific Presentations at ACR’s First Virtual Annual Meeting in November 2020
21 oct. 2020 16h05 HE
|
Exagen Inc.
SAN DIEGO, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced...
New Data Demonstrates Economic Benefit of Exagen’s AVISE® Lupus Test for Payors
12 oct. 2020 16h05 HE
|
Exagen Inc.
SAN DIEGO, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
18th U.S. Surgeon General Joins Scipher Medicine
08 oct. 2020 08h00 HE
|
Scipher Medicine Corporation
WALTHAM, Mass., Oct. 08, 2020 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with most effective therapy, has appointed former United States Surgeon General...
SetPoint Medical Receives FDA Breakthrough Device Designation for its Novel Bioelectronic Platform
06 oct. 2020 09h00 HE
|
SetPoint Medical
VALENCIA, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) -- SetPoint Medical, Inc. today announced that it has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for...
Insights on the Auto-Injectors Global Market to 2026 - Featuring Antares Pharma, Mylan & Amgen Among Others
01 oct. 2020 04h59 HE
|
Research and Markets
Dublin, Oct. 01, 2020 (GLOBE NEWSWIRE) -- The "Auto-Injectors Market Global Forecast by Regions, Application (Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Others), Product Types,...
Exagen Inc. Announces Agreement with Provider Network of America Expanding Access for AVISE® Tests to 8 Million Members
29 sept. 2020 08h25 HE
|
Exagen Inc.
SAN DIEGO, Sept. 29, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
Exagen Appoints Wendy Johnson to Board of Directors
23 sept. 2020 16h10 HE
|
Exagen Inc.
SAN DIEGO, Sept. 23, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, is proud to...